Ye, X. *, Ma, T. *, Blais, J. E., Yan, V. K. C., Kang, W., Chui, C. S. L., Lai, F. T. T., Li, X., Wan, E. Y. F., Wong, C. K. H., Tse, H. F., Siu, C. W., Wong, I. C. K., & Chan, E. W. (2022). Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease. Cardiovascular Research, 118(10), 2329-2338.
点击次数:
上一条:Huang, C. *, Wei, Y. *, Yan, V. K. C., Ye, X., Kang, W., et al. (2023). Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study. Lancet Psychiatry, 10(6), 403-413.
下一条:Ye, X., Huang, C., Yan, V. K. C., Kang, W., Fan, M., et al. (2023). Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study. European Heart Journal-Cardiovascular Pharmacotherapy, 9(5), 403-412.
